WO2026053152 - APPARATUS AND METHOD FOR UV CONVERSION OF 5,7-DEHYDROSTEROL COMPOSITIONS INTO PHOTOPRODUCTS FOR TOPICAL OR ORAL USE

National phase entry is expected:
Publication Number WO/2026/053152
Publication Date 12.03.2026
International Application No. PCT/IB2025/058938
International Filing Date 05.09.2025
Title **
[English] APPARATUS AND METHOD FOR UV CONVERSION OF 5,7-DEHYDROSTEROL COMPOSITIONS INTO PHOTOPRODUCTS FOR TOPICAL OR ORAL USE
[French] APPAREIL ET PROCÉDÉ DE CONVERSION UV DE COMPOSITIONS DE 5,7-DÉSHYDROSTÉROL EN PHOTOPRODUITS POUR UNE UTILISATION TOPIQUE OU ORALE
Applicants **
ESSE MAURITIUS
Inventors
STEYN, Trevor
GROENEWALD, Kyle Timothy
Priority Data
18/826,566   06.09.2024   US
2502571.9   21.02.2025   GB
Application details
Total Number of Claims/PCT *
Number of Independent Claims *
Number of Priorities *
Number of Multi-Dependent Claims *
Number of Drawings *
Pages for Publication *
Number of Pages with Drawings *
Pages of Specification *
*
Number of Office Actions *
*
International Searching Authority
*
Recordal of a Change of the Applicant's Name/Address
*
Type of Assignment
*
Applicant's Legal Status
*
*
*
*
*
*
Entry into National Phase under
*
Patent Delivery
*
Translation

* The data is based on automatic recognition. Please verify and amend if necessary.

** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.

Quotation for National Phase entry

Country StagesTotal
China Filing, Examination, Granting2268
EPO Filing, Examination, Granting10995
Japan Filing, Examination, Granting2356
South Korea Filing, Examination, Granting2359
USA Filing, Examination, Granting4740
MasterCard Visa
Total: 22,718
Abstract[English] The invention provides an apparatus and method for producing a topical or orally ingestible product from a composition comprising a 5,7-dehydrosterol. The apparatus includes a housing with an operative zone configured to receive and enclose the composition, and an ultraviolet (UV) light arrangement operable to irradiate the composition with one or more UV wavelengths, thereby inducing photochemical conversion into products such as previtamin D, lumisterol, tachysterol, or analogues thereof.[French] L'invention concerne un appareil et un procédé de production d'un produit topique ou ingérable par voie orale à partir d'une composition comprenant du 5,7-déshydrostérol. L'appareil comprend un boîtier ayant une zone fonctionnelle conçue pour recevoir et renfermer la composition, et un agencement de lumière ultraviolette (UV) utilisable pour irradier la composition avec une ou plusieurs longueurs d'onde UV, induisant ainsi une conversion photochimique en produits tels que la prévitamine D, le lumistérol, le tachystérol, ou des analogues de ceux-ci.

Rejoining the server...